𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to taxanes in triple negative breast cancer

✍ Scribed by Nilufer Bulut; Sadettin Kilickap; Ebru Sari; Kadri Altundag


Publisher
Springer
Year
2008
Tongue
English
Weight
119 KB
Volume
63
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Triple-negative breast cancer
✍ Rupert Bartsch; Reinhard Ziebermayr; Christoph C. Zielinski; Guenther G. Steger πŸ“‚ Article πŸ“… 2010 πŸ› Springer Vienna 🌐 German βš– 165 KB
Prognostic markers in triple-negative br
✍ Emad A. Rakha; Maysa E. El-Sayed; Andrew R. Green; Andrew H. S. Lee; John F. Rob πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 157 KB
Characteristics of triple-negative breas
✍ Tim C. de Ruijter; JΓΌrgen Veeck; Joep P. J. de Hoon; Manon van Engeland; Viviann πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 254 KB

## Background Triple-negative breast cancers (TNBC) neither express hormone receptors, nor overexpress HER2. They are associated with poor prognosis, as defined by low five-year survival and high recurrence rates after adjuvant therapy. Overall, TNBC share striking similarities with basal-like brea

How basal are triple-negative breast can
✍ FranΓ§ois Bertucci; Pascal Finetti; Nathalie Cervera; Benjamin Esterni; Fabienne πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 99 KB

## Abstract The basal molecular subtype of breast cancer (BC) is defined by the mRNA expression pattern of an intrinsic ∼500‐gene set. It is the most homogeneous subtype in transcriptional terms, and one of the most aggressive in prognostic terms. Clinical trials testing new systemic therapeutic st

Adjuvant therapy of triple negative brea
✍ Edith A. Perez; Alvaro Moreno-Aspitia; E. Aubrey Thompson; Cathy A. Andorfer πŸ“‚ Article πŸ“… 2010 πŸ› Springer US 🌐 English βš– 252 KB